Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis

Authors

Institutions

Publication Details

Journal
Military Medical Research
Published
2026-02-17
DOI
https://doi.org/10.1186/s40779-026-00686-8
Citations
1
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
46.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis

Kevin J. Tracey, Xiao-ling Qiang, Ping Wang, Brian V. Xiong et al.
1 citations
Military Medical Research
Rheumatoid Arthritis Research and Therapies
46.80
article

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis

Kevin J. Tracey, Xiao-ling Qiang, Ping Wang, Brian V. Xiong, Haichao Wang, Wei-Qiang Chen, Shu-Jin Chen, Li Lou, Cassie Shu Zhu, Huan Yang, Jian-Hua Li
article en
1 citations

Abstract

No abstract available for this paper.
Military Medical ResearchVol. 12(1)
Feinstein Institute for Medical Research (US), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
Openalex Percentile: Top 1%
Rheumatoid Arthritis Research and Therapies
46.80
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.